Dr. Scott Kamelle Recognized Among Top 10% of Cited Physicians on Doximity [Yahoo! Finance]
Doximity, Inc. Class A (DOCS)
Company Research
Source: Yahoo! Finance
Oncology at Aurora Health Care, has reached a significant career milestone. His research contributions have surpassed 750 citations, placing him among the top 10% of the most-cited physicians within the Doximity community. This achievement underscores his impact on advancing gynecologic cancer research and improving patient care through evidence-based medicine. Doximity, the leading digital platform for medical professionals, tracks and aggregates citations as a measure of scholarly influence and contribution to the medical field. Being ranked in the top 10% is a testament to Dr. Kamelle's dedication to research, education, and innovation in gynecologic oncology. His extensive body of work has helped shape best practices in the diagnosis and treatment of ovarian and uterine cancers, as well as robotic-assisted surgical techniques. A Legacy of Research Excellence Dr. Scott Kamelle's career has been defined by a commitment to clinical excellence and scientific discovery. With a ba
Show less
Read more
Impact Snapshot
Event Time:
DOCS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DOCS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DOCS alerts
High impacting Doximity, Inc. Class A news events
Weekly update
A roundup of the hottest topics
DOCS
News
- Doximity (DOCS): Taking Stock of Valuation After Analyst Upgrades on AI Tools and Growth Outlook [Yahoo! Finance]Yahoo! Finance
- Doximity (NASDAQ:DOCS) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating.MarketBeat
- Doximity (NYSE:DOCS) is now covered by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>. They set a "hold (c+)" rating on the stock.MarketBeat
- Doximity (NYSE:DOCS) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.MarketBeat
- Doximity (NYSE:DOCS) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=DOCS&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> froMarketBeat
DOCS
Earnings
- 11/6/25 - Beat
DOCS
Sec Filings
- 12/3/25 - Form 4
- 12/1/25 - Form 144
- 11/24/25 - Form 4
- DOCS's page on the SEC website